a “miracle helper” on the way to anti-infection—— Clindamycin
Clindamycin is mainly used to treat infections caused by sensitive strains of streptococcus, staphylococcus and anaerobic bacteria, such as skin infections, respiratory infections, etc. Clindamycin has the same antibacterial spectrum as lincomycin and higher antibacterial activity than lincomycin.
The antibacterial spectrum of Clindamycin is the same as Lincomycin, and the antibacterial activity is higher than Lincomycin. Clindamycin mainly acts on the 50S subunit of the ribosome of sensitive bacteria, preventing the extension of peptide chain, thus inhibiting the protein synthesis of bacterial cells. Its derivative clindamycin phosphate has no antibacterial activity in vitro, and is rapidly hydrolyzed to clindamycin to exert antibacterial activity after entering the body.
Clindamycin has strong anti-infective ability and wide therapeutic range, and is widely used in the treatment of various types of infections.
However, clindamycin is prone to various impurities during the production process, which may affect the safety and efficacy of the drug. Pharmacopoeias of various countries have made relevant regulations on the limits of impurities related to Clindamycin API and its preparations.
SZEB focuses on the comprehensive solution of drug impurity control products, the advantage of the supply of Clindamycin impurities and Clindamycin phosphate impurities, to help solve the majority of scientific research institutions as well as enterprises on the analysis of these impurities, the following is the Clindamycin impurity control/standard products (part) catalog, more impurity information please go to the official website: https://www.ex-biotech.com/ .Welcome to consult if you need.,we are willing to serve you .